Near Infrared Imaging Market: Global Market Analysis and Forecast (2024-2030)

Near Infrared Imaging Market was valued at US$ 1.04 Bn. in 2023. Global near Infrared Imaging Market size is expected to grow at a CAGR of 11 % through the forecast period.
Near Infrared Imaging Market Overview:
Near Infrared Imaging has wide range of uses like Physiological diagnostics, the study of pulse oximetry, blood sugar, sports medicine, urology, and neurology. Light with a wavelength between 650 and 950 nm is used in near infrared imaging to find any damage, illness, or artificial changes. It is a potent diagnostic tool for non-ionizing, minimally invasive tissue imaging. Given that it offers better resolution and poses a greater risk to patients, it is preferable to other procedures.To know about the Research Methodology :- Request Free Sample Report

2023 is considered as a base year to forecast the market from 2024 to 2030. 2023’s market size is estimated on real numbers and outputs of the key players and major players across the globe. Past five years' trends are considered while forecasting the market through 2030. 2023 is a year of exception and analysis especially with the impact of lockdown by region.
Dynamics:
Market Drivers: There are more surgical procedures being performed with the increasing prevalence and incidence of numerous diseases like cancer, cardiovascular disease, neurovascular disease, and gastrointestinal disease. The rise in surgical treatments is also being fueled by trauma cases and surgical cosmetic procedures. NIR imaging is employed for intraoperative imaging during a variety of surgical operations, including plastic and reconstructive surgeries, cancer surgeries, gastrointestinal surgeries, cardiovascular surgeries, cardiothoracic surgeries, and neurovascular surgeries. NIR imaging helps surgeons to evaluate blood flow, tissue viability, and perfusion during these operations. NIR imaging is utilized in cancer procedures to create positive margins that aid in separating malignant tumors from healthy tissues. As a result, NIR imaging market is expected to be driven by the rising number of surgical procedures.

Market Restraints: Only methylene blue and indocyanine green (ICG) are NIR fluorophores that received FDA approval for clinical use in 1959. ICG and MB are blood pool agents, however, and as such are not the best fluorophores for fluorescence image-guided surgery because they are neither specific for malignancies nor healthy tissues. The visibility of the target tissues mostly depends on the efficacy of fluorescent agents because the degree of molecular absorption into the target and nearby normal tissues differs. Targeted fluorophores make it possible to see the intended target tissues, improving clinical results. However, the lack of US Food and Drug Administration (FDA) approvals has largely prevented the adoption of tailored fluorophores.

Additionally, imaging agents must go through the same FDA approval procedure as other pharmaceutical medications, which may add an additional ten years and $150 million to the time it takes for fluorescence probes to hit the market. Imaging agents must be coupled with a particular make and model of imaging instrument after approval. For instance, the Cysview (Photocure) with the PDD System blue light cystoscope from KARL STORZ was approved. This approach restricts the use of molecularly tailored NIRF imaging agents in clinical settings, which restrains the near infrared market's growth.

Market Opportunities: For significant participants in the NIR imaging market, emerging markets like India, China, Brazil, South Korea, Turkey, Russia, and South Africa present high-growth prospects. These developing nations' high population densities particularly in India and China provide a long-term market for imaging devices notwithstanding the cost issue. India and China are home to a sizable patient base because they house more than half of the world's population. In Asia, there were 8,750,932 cancer cases reported in 2018, according to GLOBOCAN. Players in the NIR imaging market are growing their presence in emerging economies as a result of the rapid economic development and rising disposable incomes that are encouraging people in these nations to spend on high-quality healthcare services.

Along with the previously mentioned elements, regulatory regulations in the Asia Pacific region are more flexible and business-friendly. Imaging system makers are expected to shift their attention to emerging markets as a result of growing competition in mature areas. The life sciences research market in these nations has experienced significant growth as a result of cost advantages, the availability of skilled researchers the growth of research institutions, and all of these factors combined. The need for numerous imaging modalities including NIR imaging has expanded with the growth of the life sciences research sector.

Market Challenges: NIR imaging is a sophisticated imaging method that requires trained operators to use it effectively. A major barrier to the adoption of these systems for clinical applications at the moment is the lack of experienced operators particularly in poor nations. Additionally, the technological environment of the NIR market is continually changing as more cutting-edge products are introduced on a yearly basis. NIR fluorescence imaging is currently available for laparoscopic, thoracoscopic, and robot-assisted surgeries in addition to devices for open surgery. This forces medical professionals and other healthcare professionals to learn the essential skills to effectively use these cutting-edge NIR imaging technologies.

As a result, the adoption of these imaging systems by doctors and other healthcare professionals is on hold which hinders near infrared market growth. On the other hand, organizations like Carl Zeiss conduct a variety of courses and training sessions on intraoperative fluorescence. To better explain the science and application of these gadgets, these businesses show clinical scenarios along with actual surgeries. These manufacturers' initiatives might help to solve this problem in the future.

COVID-19 Impact on Near Infrared Imaging Market:

The COVID-19 epidemic has had an effect on the medical device sector globally, notably interventional neurology devices. Despite the urgency, there have been much fewer patient visits to hospitals during the last six months. The COVID-19 epidemic has resulted in significant heterogeneity in how surgical procedures are managed. In order to avoid coming into contact with COVID-19 patients and healthcare workers, patients are avoiding healthcare facilities. A number of acute and serious illnesses, including stroke, myocardial infarction, and other malignancies have shown declining rates. The temporary deferral of a number of elective surgeries is expected to have an impact on the market for near-infrared imaging as governments and agencies work to ensure that resources are available for COVID-19 patients. Reduced enrollment in clinical trials and shuttered production facilities has further hampered the growth of the total near-infrared imaging market in 2020.
Near Infrared Imaging Market Segment Analysis:
Based on Type, The reagents category dominated the market for near-infrared imaging with a 56.2 % revenue share in 2023. The segment is expected to grow at CAGR of xx% over the forecast period, since reagents provide various advantages over conventional visible light dyes, including high sensitivity and precise detection in biological systems. Indocyanine Green (ICG) and other reagents are subcategories of reagents. Due to the advantages provided by ICG, the reagents segment is expected to increase significantly during the forecast period. Angiographic images in real-time are provided using indocyanine green during brain tumor or vascular surgery. Additionally, spine surgery is using it more and more. ICG's advantages and expanding applications are segment's main drivers.

Based on the End Use, The hospitals and clinics segment took the lead with a revenue share of 44.8% in 2023. This surge is attributable to an increase in the number of cancer patients being admitted to hospitals, clinics, and other reputable healthcare institutions in industrialized nations. In order to identify bedsores and avoid surgical mistakes, near-infrared technology is frequently employed in hospitals and clinics. Using laparoscopic tools equipped with near-infrared sensors, surgeons can prevent accidentally severing blood arteries. Adoption of these tools aids in lowering surgical mistake rates, shortening hospital stays, and lowering patient healthcare expenses. It is expected that demand will increase as a patient's desire for effective and minimally invasive surgical techniques grow.

The pharmaceutical and biotechnology firms market is also expected to experience a sizable CAGR during the forecast period. Pharmaceutical businesses employ near-infrared imaging to assess a product's essential material characteristics. They are used in pharmaceutical and biotechnology companies for a variety of in-line and online process monitoring tasks including raw material identification, lyophilized material quality assurance, tablet coating, and content monitoring, cell culture and fermentation monitoring, and process identification of raw materials.
Regional Insights:
The North American region dominated the market with a 40.1 % share in 2023. This growth is attributable to consumer spending power, the quick uptake of cutting-edge medical technology, and diagnostic methods. The U.S. market is expected to grow as a result of the high number of cancer cases that have been documented there. The American Cancer Society estimates that there were around 1685,210 new cancer cases in the United States in 2023. Additionally, the country's increase in reconstructive and cosmetic procedures due to higher spending and growing awareness of early diagnosis is expected to generate significant growth potential.

The Asia Pacific region is expected to witness significant growth at a CAGR of 12% through the forecast period. It is expected that the presence of developing nations like China, India, and Japan will accelerate the growth of the regional market. The Asia Pacific region has a sizable population base and a low per capita income, which has increased the need for accessible treatment choices. International corporations are eager to make investments in developing nations like Japan, India, South Korea, and others. As a result, a lot of global market companies are forming strategic partnerships with regional ones. This is expected to accelerate the near-infrared imaging market growth.

The objective of the report is to present a comprehensive analysis of the global Near Infrared Imaging Market to the stakeholders in the market. The past and current status of the market with the forecast market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the market with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the market to the decision-makers.

The reports also help in understanding the Near Infrared Imaging Market dynamic, structure by analyzing the market segments and projecting the Near Infrared Imaging Market size. Clear representation of competitive analysis of key players by Vehicle type, price, financial position, product portfolio, growth strategies, and regional presence in the Near Infrared Imaging Market make the report investor’s guide.
Near Infrared Imaging Market Scope: Inquire before buying



Global Near Infrared Imaging Market


Report Coverage
Details


Base Year:
2023
Forecast Period:
2024-2030


Historical Data:
2018 to 2023
Market Size in 2023:
US$ 1.04 Bn.


Forecast Period 2024 to 2030 CAGR:
11%
Market Size in 2030:
US$ 2.16 Bn.


 Segments Covered:
by Type
Device
Reagent


by Application
Preclinical Imaging
Cancer Surgeries
Gastrointestinal Surgeries
Cardiovascular Surgeries
Plastic/Reconstructive Surgeries
Other Applications


by End Use
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Research Laboratories



Near Infrared Imaging Market by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Near Infrared Imaging Market Key Players
1. Stryker
2. Karl Storz Se & Co.Kg
3. Carl Zeiss Meditech AG
4. Leica Microsystems
5. Olympus Corporation
6. PerkinElmer, Inc.
7. Li-Cor, Inc.
8. Hamamatsu Photonics K.K.
9. Quest Medical Imaging B.V.
10.Mizuho Medical Co., Ltd.
11.Fluoptics
12.Shimadzu Corporation
13.Medtronic
14.SurgVision
15.Merk & Co Inc
16.Thermo Fisher Scientific

Frequently Asked Questions:

1] What segments are covered in the Global Near Infrared Imaging Market report?
Ans. The segments covered in the Near Infrared Imaging Market report are based on Type, Application and End Use.

2] Which region is expected to hold the highest share in the Global Near Infrared Imaging Market?
Ans. The North America region is expected to hold the highest share in the Near Infrared Imaging Market.

3] What is the market size of the Global Near Infrared Imaging Market by 2030?
Ans. The market size of the Near Infrared Imaging Market by 2030 is expected to reach US$ 2.16 Bn.

4] What is the forecast period for the Global Near Infrared Imaging Market?
Ans. The forecast period for the Near Infrared Imaging Market is 2024-2030.

5] What was the market size of the Global Near Infrared Imaging Market in 2023?
Ans. The market size of the Near Infrared Imaging Market in 2023 was valued at US$ 1.04 Bn.